Homepage neurodiem
Conferences Talks About
Search
Interview Interview Expert talks and scientific presentations by local and international clinicians and scientists. Published: Jul 20, 2020

Next-generation sequencing: limitations in the diagnosis of neuromuscular diseases

Prof. Abrams provides an overview of next-generation sequencing, focusing on challenges for the diagnosis of genetic neuromuscular conditions.

Dr Abrams is / was a consultant / advisor for Atheneum Partners, Guidepoint network and Stealth BioTherapeutics.

Learn more

Neuromuscular Genetics Oculopharyngeal muscular dystrophy Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS) Neuropathy ataxia and retinitis pigmentosa (NARP) Myoclonic epilepsy with ragged-red fibers (MERRF) Hereditary neuropathy with liability to pressure palsy (HNPP) Chronic progressive external ophthalmoplegia (CPEO) Facioscapulohumeral muscular dystrophy c9orf72 mutation CMT1A spinal bulbar muscular atrophy Myotonic Dystrophy SMN2 gene SMN1 gene ALS next-generation sequencing whole exome sequencing whole-genome sequencing
Home All Topics Conferences Menu

News Conferences Talks Search Sign Up Log In

Cognition Critical Care Dementia Depression Epilepsy Genetics Headache
Imaging Movement Disorders Multiple Sclerosis Neuro-Oncology Neuro-Ophthalmology Neuromuscular
Neurosurgery Paediatric Neurology Pain Rehabilitation Sleep Stroke

Scientific journals

About Neurodiem Editorial policy Terms of Use Privacy policy FAQ Contact us

Denmark
Copyright © 2018 - 2022 Neurodiem. All rights reserved.
The content of this website is intended for healthcare professionals. NEURODIEM is a service from Biogen MA Inc. The information presented on Neurodiem will in no way be selected, modified or altered by Biogen. Neurodiem does not contain any promotional content.